Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Decision date

Orphan disease / condition

Orphan decision number

Orphan designation status

Medicine type

Related medicine

Last updated

First published

1 results

Sort by

List item

Orphan designation: Mepolizumab for: Treatment of hypereosinophilic syndrome

Date of first decision: 29/07/2004, Withdrawn, Last updated: 23/10/2020